skip navigation

Skip Nav

Clinical Guidelines Portal

Clinical Guidelines Portal

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

Appendix C: Panel Roster and Financial Disclosures

Toxo

(Last updated: September 1, 2014; last reviewed: September 1, 2014)

Toxoplasma gondii Encephalitis

Member Financial Disclosure
 Company Relationship
Boyd, Sarita Food and Drug Administration None N/A
Chow, Felicia University of California, San Francisco Gilead Stock Holder
Kovacs, Joe*  National Institutes of Health None N/A
Lai, Leon
 
 
 
 
 
 
 
Washington Hospital Center
 
 
 
 
 
 
 
Advanced Medical Stock Holder
Amgen Stock Holder
Bristol-Myers Squibb Stock Holder
DuPont Stock Holder
Eli Lilly & Co. Stock Holder
Merck Stock Holder
Pfizer Stock Holder
Schering-Plough Stock Holder
Miro, Jose M. Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain Abbvie Consultant, Honoraria, Speaker's Bureau
Astellas Consultant
Bristol-Myers Squibb Consultant, Honoraria, Research Support, Speaker's Bureau
Cubist Advisory Board, Consultant, Honoraria, Research Support, Speaker's Bureau
Fundacion Maximo Soriano Jimenez, Barcelona, Spain
Research Support
Gilead Consultant, Honoraria, Speaker's Bureau
GlaxoSmithKline Honoraria, Speaker's Bureau
Instituto de Salud Carlos III, Spanish Ministry of Health, Madrid, Spain
Research Support
Janssen-Cilag Speaker's Bureau
Merck Consultant, Speaker's Bureau
National Institutes of Health Research Support
Novartis Advisory Board, Consultant, Honoraria, Research Support, Speaker’s Bureau
Pfizer Consultant, Speaker's Bureau
ViiV Healthcare Honoraria, Speaker's Bureau, Research Support
Montoya, Jose Stanford University None N/A
Podzamczer, Daniel
Hospital Universitari de Bellvitge, Spain
Abbott Advisory Board, Speaker's Bureau
Boehringer Ingelheim Advisory Board, Research Support, Speaker's Bureau, Travel Support
Bristol-Myers Squibb Advisory Board, Speaker's Bureau
GlaxoSmithKline Advisory Board, Research Support, Speaker's Bureau
Janssen-Cilag Advisory Board, Speaker's Bureau
Merck Advisory Board, Speaker's Bureau
Pfizer Advisory Board, Research Support, Speaker's Bureau
ViiV Advisory Board, Research Support, Speaker's Bureau

* Group lead; Divested

Note: Members were asked to disclose all relationships from 24 months prior to the update date. The period of reporting was from September 1, 2012, through September 1, 2014.

Back to Top